These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29361270)

  • 21. COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population.
    Hubacek JA; Adamkova V; Zlatohlavek L; Steiner-Mrazova L; Vrablik M
    Drug Metab Pers Ther; 2017 Dec; 32(4):177-182. PubMed ID: 29257754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
    Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy.
    Danik JS; Chasman DI; MacFadyen JG; Nyberg F; Barratt BJ; Ridker PM
    Am Heart J; 2013 Jun; 165(6):1008-14. PubMed ID: 23708174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MY APPROACH to Managing Statin-Associated Muscle Symptoms.
    Thompson PD
    Trends Cardiovasc Med; 2017 Feb; 27(2):160-161. PubMed ID: 28107840
    [No Abstract]   [Full Text] [Related]  

  • 26. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
    Iatan I; Mancini GBJ; Yeoh E; Hegele RA
    Expert Rev Cardiovasc Ther; 2023 Jun; 21(6):423-435. PubMed ID: 37212306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLCO1B1 variants and statin-induced myopathy.
    Vladutiu GD; Isackson PJ
    N Engl J Med; 2009 Jan; 360(3):304. PubMed ID: 19144951
    [No Abstract]   [Full Text] [Related]  

  • 28. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
    Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
    Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
    Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
    J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonadherence to statins: individualized intervention strategies outside the pill box.
    Lansberg P; Lee A; Lee ZV; Subramaniam K; Setia S
    Vasc Health Risk Manag; 2018; 14():91-102. PubMed ID: 29872306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin intolerance.
    Laufs U; Scharnagl H; März W
    Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simvastatin monotherapy as a potential option for statin-associated muscle symptoms: a case report.
    Qu H; Guo M; Kou N; Wu HT; Zhang Y; Gao ZY; Shi DZ
    J Clin Pharm Ther; 2016 Oct; 41(5):568-71. PubMed ID: 27425755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decoding the Intricacies of Statin-Associated Muscle Symptoms.
    Rastegar TF; Khan IA; Christopher-Stine L
    Curr Rheumatol Rep; 2024 Jul; 26(7):260-268. PubMed ID: 38575845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience.
    Ward NC; Pang J; Ryan JDM; Watts GF
    Clin Cardiol; 2018 Jan; 41(1):159-165. PubMed ID: 29363784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.
    Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K
    Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features related to statin-associated muscle symptoms.
    Ochs-Balcom HM; Nguyen LM; Ma C; Isackson PJ; Luzum JA; Kitzmiller JP; Tarnopolsky M; Weisman M; Christopher-Stine L; Peltier W; Wortmann RL; Vladutiu GD
    Muscle Nerve; 2019 May; 59(5):537-543. PubMed ID: 30549046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance.
    Bigossi M; Maroteau C; Dawed AY; Taylor A; Srinivasan S; Melhem AL; Pearson ER; Pola R; Palmer CNA; Siddiqui MK
    Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):536-545. PubMed ID: 37253618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment Options for Statin-Associated Muscle Symptoms.
    Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
    Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.